Stock Events

Stock Events

VYNE Therapeutics (VYNE) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.3

-0.27

-0.23

-0.19

Details

Expected EPS

-0.28835

Actual EPS

-0.2

Surprise EPS

0.09

Surprise Percent

+30.64%

Description

VYNE Therapeutics (VYNE) has reported earnings of -0.2 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.